NSE filing, NSE: KOTYARK. Summary written from the filing by ALFA Finder's alert engine.
Kotyark Industries Ltd: key numbers
- Share price
- ₹38.99
- Market cap
- ₹440.9 Cr
- Revenue (annual)
- ₹314.9 Cr
- Net profit (annual)
- ₹19.36 Cr
- P/E (TTM)
- 20.0×Sector 21.0×
- Promoter holding
- 57.34%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kotyark Industries Ltd
All →Kotyark Industries Q2 FY27 Results: Net Profit ₹6.2 Cr, Up 148.0% YoY
Kotyark Industries Ltd reported revenue from operations of ₹61.3 Cr (-5.5% YoY) and net profit of ₹6.2 Cr (+148.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6.2 Cr · +148.0% YoY
Kotyark Industries Board Meeting Date
Kotyark Industries will hold a board meeting on 28 October 2026 to consider unaudited consolidated and standalone results for the quarter and half year ended 30 September 2026. The trading window has been closed since 01 October 2026.
Kotyark Industries Legal & Regulatory
The Board addressed the exchange fines for the delayed submission of Q1 FY2026 financial results, attributing the delay to a change in statutory auditors. Fines are paid.
Kotyark Industries Other Announcement
Kotyark Industries Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations for the period ended September 30, 2026.
Kotyark Industries Board Meeting Date
Kotyark Industries scheduled a board meeting for October 12, 2026, to discuss fund-raising proposals, including preferential issue of shares and ESOPs.
Kotyark Industries Investor Presentation: Key Takeaways
Kotyark Industries reported steady Q1FY27 consolidated revenue growth of 11.5% YoY with a 30.54% surge in PBT, driven by biodiesel demand.
- Call
- Guides 30% growth
Other results update announcements
All →Fino Payments Bank Results Update
Fino Payments Bank's press release reports Q2 FY27 revenue of Rs.333.6 Crore and a H1 net loss. Loan referral disbursals surged 286% year-on-year.
Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.
Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Capital Small Finance Bank Results Update
Capital SFB's Q2 FY27 PAT rose 30.7% year-on-year to ₹45.61 crore, while advances grew 23.4%. Asset quality improved, with GNPA at 2.36% and NNPA at 1.12%.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.